Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
We further demonstrate that oxidative mitochondrial signalling can be used as a biomarker of response to fluoropyrimidine-based chemotherapy treatment in patients with CRC and may have clinical utility for stratifying patients at higher risk who could benefit from metabolically targeted combination therapies
Shares jumped 9.8% on the report and added another 4.32% in the week since
It has been extensively studied in pre-clinical models across gastrointestinal, musculoskeletal, and neurological research contexts
Orders placed after 1pm EST or on weekends will be shipped the next business day to meet research schedules
16 weeks 2-3 x 10 mL bottles Approx 15 mL retatrutide + 8-14 mL CJC/Ipa across the cycle
US$ 22.32
US$ 27.15
US$ 24.77
